ZTS Zoetis Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZTS

Price (delayed)

$159.91

Market cap

$75.26B

P/E Ratio

36.59

Dividend/share

$1.15

EPS

$4.37

Enterprise value

$78.86B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
The P/E is 25% lower than the last 4 quarters average of 48.2 and 11% lower than the 5-year quarterly average of 41.0
The net income has grown by 17% YoY
Zoetis's quick ratio has decreased by 44% QoQ and by 37% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.zoetis.com/
Peers: LLY MRK PFE PAHC

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
470.63M
Market cap
$75.26B
Enterprise value
$78.86B
Valuations
Price to earnings (P/E)
36.59
Price to book (P/B)
16.2
Price to sales (P/S)
9.57
EV/EBIT
28.67
EV/EBITDA
24.61
EV/Sales
9.99
Earnings
Revenue
$7.89B
EBIT
$2.75B
EBITDA
$3.2B
Free cash flow
$1.61B
Per share
EPS
$4.37
Free cash flow per share
$3.41
Book value per share
$9.87
Revenue per share
$16.71
TBVPS
$20.64
Balance sheet
Total assets
$13.86B
Total liabilities
$9.2B
Debt
$6.74B
Equity
$4.66B
Working capital
$3.8B
Liquidity
Debt to equity
1.45
Current ratio
2.25
Quick ratio
1.44
Net debt/EBITDA
1.12
Margins
EBITDA margin
40.6%
Gross margin
70.6%
Net margin
26.3%
Operating margin
34.8%
Efficiency
Return on assets
14.9%
Return on equity
45.5%
Return on invested capital
24.9%
Return on capital employed
25.4%
Return on sales
34.9%
Dividend
Dividend yield
0.72%
DPS
$1.15
Payout ratio
26.3%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
0.81%
1 week
-3.28%
1 month
-14.84%
1 year
-9.04%
YTD
-34.47%
QTD
-15.21%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$7.89B
Gross profit
$5.57B
Operating income
$2.75B
Net income
$2.07B
Gross margin
70.6%
Net margin
26.3%
The net income has grown by 17% YoY
The gross profit has grown by 14% YoY
Zoetis's operating income has increased by 14% YoY
ZTS's revenue is up by 13% YoY

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
P/E
36.59
P/B
16.2
P/S
9.57
EV/EBIT
28.67
EV/EBITDA
24.61
EV/Sales
9.99
The P/E is 25% lower than the last 4 quarters average of 48.2 and 11% lower than the 5-year quarterly average of 41.0
Zoetis's EPS has increased by 17% YoY
The stock's price to book (P/B) is 24% less than its last 4 quarters average of 21.1 and 22% less than its 5-year quarterly average of 20.6
ZTS's equity is up by 14% year-on-year and by 2.5% since the previous quarter
ZTS's price to sales (P/S) is 25% lower than its last 4 quarters average of 12.6
ZTS's revenue is up by 13% YoY

Efficiency

How efficient is Zoetis business performance
ZTS's return on assets is up by 14% year-on-year
ZTS's ROIC is up by 14% YoY and by 3.3% QoQ
The company's return on equity fell by 7% YoY

Dividends

What is ZTS's dividend history
Dividend details
DPS
$1.15
Dividend yield
0.72%
Payout ratio
26.3%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 51% greater than its total liabilities
Zoetis's quick ratio has decreased by 44% QoQ and by 37% YoY
The company's current ratio fell by 42% QoQ and by 32% YoY
The debt is 45% higher than the equity
Zoetis's debt to equity has decreased by 19% YoY and by 2% QoQ
ZTS's equity is up by 14% year-on-year and by 2.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.